All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Amundi›LHTC

LHTC

Amundi STOXX Europe 600 Healthcare UCITS ETF

Acc

EUR

Passive ETF Equity

The LHTC Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: STOXX Europe 600 Health Care Index. This ETF provides synthetic exposure, by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap (i.e. a contract with a financial institution which delivers the return of the index). The dividend policy is capitalization.

€152.71

N/A

Data as of 07/22/26

1D price range

N/A

52W price range

€128.87€163.35

YTD Perf.

+1.05%

YTD Flows

Annualized volatility

Fund AuM

€909M

Share class AuM

€839M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

LU1834986900

TER

0.3%

Inception date

8/18/2006

Issuer

Amundi

Benchmark

STOXX Europe 600 Health Care Index

Replication method

Dividend policy

Capitalization

Compare similar ETFs

No content available for this fund

API

PerformanceDec 31, 2025 - Jul 22, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

94.48%

Consumer Cyclicals

3.02%

Non-Energy Materials

1.13%

Unavailable

0.63%

Other

0.74%

Latest LHTC news

Biotech ETFs Surge as the FDA Eases Its Stance

Moving Markets · June 29, 2026

Trump’s Victory Fuels U.S. Equity ETFs Surge While Europe Faces Some Market Setbacks

Moving Markets · November 8, 2024

FAQ about LHTC

LHTC is a Passive ETF. This ETF provides exposure to European Health Care Equities.

LHTC tracks the STOXX Europe 600 Health Care Net Return Index - EUR, through a unfunded swap replication method.

LHTC carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.

LHTC was introduced to the market on August 18, 2006. It trades on Denmark, among other exchanges

Amundi STOXX Europe 600 Healthcare UCITS ETF, LHTC, is provided by Amundi. Learn more about Amundi here.

Yes, LHTC is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

LHTC oversees €839M in assets as of July 22, 2026.

LHTC follows a capitalizing, meaning it reinvests income within the fund.

As of June 30, 2026, LHTC has significant geographic allocations in Switzerland, United Kingdom and Denmark.

As of June 30, 2026, LHTC focuses largely on Healthcare, Consumer Cyclicals and Non-Energy Materials.

As of June 30, 2026, LHTC holds 46 positions in its portfolio, with 84.46% of assets concentrated in its top 15 holdings.

As of June 30, 2026, LHTC top three holdings include Novartis AG, AstraZeneca PLC and Roche Holding AG.

The base currency of LHTC is EUR.

Top 10 holdings

Data as of 06/30/26

Novartis AG

15.37%

AstraZeneca PLC

14.86%

Roche Holding AG

14.58%

Novo Nordisk A/S

7.95%

GSK Plc

5.48%

Sanofi

4.96%

EssilorLuxottica SA

3.02%

argenx SE

2.97%

Bayer AG

2.80%

Lonza Group AG

2.44%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Amundi STOXX Europe 600 Healthcare UCITS ETF

FAQ about LHTC

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US